Enteroviral encephalitis in a patient with a marginal zone lymphoma treated with rituximab

Netherlands Journal of Medicine

Volumn 68, Issue 5, 2010, Pages 221-223

  Schilthuizen, C ^a   Berenschot, H W A ^a   Levin, M D ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

B cells; Enteroviral encephalitis; Hypogammaglob ulinaemia; Marginal zone lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LAXATIVE; LEVOTHYROXINE; METOCLOPRAMIDE; MIRTAZAPINE; MOVICOLON; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE; VIRUS ANTIBODY; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CANCER STAGING; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ENTEROVIRUS INFECTION; FATIGUE; FECES CULTURE; FEMALE; FEVER; HUMAN; IMMUNOGLOBULIN G DEFICIENCY; LABORATORY TEST; MAINTENANCE THERAPY; MARGINAL ZONE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; PHYSICAL EXAMINATION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; VIRUS ENCEPHALITIS; VOMITING; WEIGHT REDUCTION; AGAMMAGLOBULINEMIA; CHEMICALLY INDUCED; ENCEPHALITIS, VIRAL; ENTEROVIRUS INFECTIONS; IMMUNOLOGY; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; VIROLOGY;

AGAMMAGLOBULINEMIA; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ENCEPHALITIS, VIRAL; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED;

EID: 77953305925     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Melnick JL. The discovery of the enteroviruses and the classification of poliovirus among them. Biologicals. 1993;21(4):305-309.
2. Kogon A, Spigland I, Frothingham TE, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol. 1969;89(1):51-61.
3. McKinney RE, Jr., Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987;9(2):334-356.
4. Misbah SA, Spickett GP, Ryba PC, et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol. 1992;12(4):266-270.
5. Quartier P, Foray S, Casanova JL, Hau-Rainsard I, Blanche S, Fischer A. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J. 2000;19(11):1106-1108.
6. Padate BP, Keidan J. Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab. Clin Lab Haematol. 2006;28(1):69-71.
7. Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leucoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood. 2002;99(4):1486-1488.
8. Quartier P, Tournilhac O, Archimbaud C, et al. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis. 2003;36(3):e47-49.
9. Ganjoo KN, Raman R, Sobel RA, Pinto HA. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy. Leuk Lymphoma. 2009; 50(4);673-675.
10. Archimbaud C, Bailly JL, Chambon M, Tournilhac O, Travade P, Peigue-Lafeuille H. Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000. J Clin Microbiol. 2003;4i(i0):4605-4610.
11. Kiani-Alikhan S, Skoulidis F, Barroso A, Nuovo G, Ushiro-Lumb I, Breuer J, et al. Enterovirus infection of neuronal cells post-Rituximab. Br J Haematol. 2009;46(3);333-335.
12. Cheson BD. CHOP plus rituximab--balancing facts and opinion. New Engl J Med. 2002;346(4):280-282.
13. van Meerten T, Hagenbeek A. CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma. Neth J Med. 2009;67(7):251-259.
14. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood. 2000;96(3):1184-1186.
15. Bermudez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica. 2000;85(8):894-895.